Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Grant or award President and CEO acquired 282,529 shares (grant or award)
  2. 4 Grant or award Director acquired 10,690 shares (grant or award)
  3. 4 Grant or award Director acquired 10,690 shares (grant or award)
  4. 4 Grant or award Director acquired 10,690 shares (grant or award)
  5. 4 Grant or award Director acquired 10,690 shares (grant or award)
  6. 4 Grant or award Director acquired 10,690 shares (grant or award)
  7. 4 Planned sale President and CEO sold 21,000 shares at $19.79 ($415,590)
  8. 4 Planned sale President and CEO sold 21,000 shares at $16.00 ($336,000)
  9. 4 Planned sale President and CEO sold 21,000 shares at $16.00 ($336,000)
  10. 4 Planned sale President and CEO sold 21,000 shares at $16.13 ($338,730)
  11. 4 Planned sale President and CEO sold 21,000 shares at $16.88 ($354,480)
  12. 4 Shares withheld for taxes COO and SVP, Compliance gave up 1,208 shares (to pay taxes)
  13. 4 Shares withheld for taxes COO and SVP, Compliance gave up 3,027 shares (to pay taxes)
  14. 4 Shares withheld for taxes CFO and Treasurer gave up 7,123 shares (to pay taxes)
  15. 4 Planned sale President and CEO sold 21,000 shares at $18.66 ($391,860)
  16. 4 Shares withheld for taxes CFO and Treasurer gave up 9,838 shares (to pay taxes)
  17. 4 Planned sale President and CEO sold 21,000 shares at $20.81 ($437,010)
  18. 4 Open-market sale Director sold 425,621 shares at an average $20.74 ($8,829,333)
  19. 4 Open-market sale Director sold 20,000 shares at $20.96 ($419,200)
  20. 4 Open-market sale Director sold 10,000 shares at $21.31 ($213,100)

Page 2 of 19 · 362 filings